New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
A newly published randomized controlled trial in the Journal of the American Academy of Dermatology demonstrates that STRATA Skin Sciences' XTRAC 308-nm excimer laser, combined with oral JAK inhibitors, achieves unprecedented repigmentation response rates in pediatric vitiligo patients, with strong safety and quality-of-life benefits. This validate…